FDA Announces Draft Guidance on Animal Drug User Fees Waivers and Reductions

Summary

The Food and Drug Administration (FDA) has released a draft guidance outlining the procedures for evaluating waiver requests under the Animal Drug User Fee Act of 2003, which aims to address situations where user fees exceed the costs of drug development.